Steven Cohen Neuro Pace Inc Transaction History

Point72 Asset Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$5.9 - $11.93 $194,363 - $393,009	32,943 New	32,943 $368,000
Q3 2022 Nov 14, 2022	SELL	$3.1 - $5.98 $10,837 - $20,906	-3,496 Reduced 2.34%	145,703 $546,000
Q2 2022 Aug 15, 2022	SELL	$4.95 - $8.7 $296,886 - $521,799	-59,977 Reduced 28.67%	149,199 $739,000
Q1 2022 May 16, 2022	BUY	$7.06 - $11.57 $515,210 - $844,332	72,976 Added 53.58%	209,176 $1.72 Million
Q4 2021 Feb 14, 2022	BUY	$8.63 - $17.36 $1.18 Million - $2.36 Million	136,200 New	136,200 $1.37 Million

Ticker NPCE
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,846,900
Market Cap $319M
Description
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.